Introduction: Examination of clinical and preclinical pharmacologic data relating to abuse liability of l‐deprenyl (selegiline)

Steven R. Goldberg, Sevil Yasar, Jack Bergman, Moussa B.H. Youdim

Research output: Contribution to journalArticle

Abstract

Clinical Pharmacology and Therapeutics (1994) 56, 721–724; doi:

Original languageEnglish (US)
Pages (from-to)721-724
Number of pages4
JournalClinical Pharmacology & Therapeutics
Volume56
DOIs
StatePublished - Dec 1994

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Introduction: Examination of clinical and preclinical pharmacologic data relating to abuse liability of l‐deprenyl (selegiline)'. Together they form a unique fingerprint.

  • Cite this